{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T09:50:26Z","timestamp":1677318626461},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12185-022-03453-2","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T05:42:47Z","timestamp":1663911767000},"page":"283-286","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous\u00a0MEFV\u00a0mutation"],"prefix":"10.1007","volume":"117","author":[{"given":"Shiori","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Fujinami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asahi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"3453_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1182\/blood.2019003599","volume":"135","author":"O Miltiadous","year":"2020","unstructured":"Miltiadous O, Hou M, Bussel JB. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment. Blood. 2020;135:472\u201390.","journal-title":"Blood"},{"key":"3453_CR2","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829\u201366.","journal-title":"Blood Adv"},{"key":"3453_CR3","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.2147\/DDDT.S299591","volume":"15","author":"JB Bussel","year":"2021","unstructured":"Bussel JB, Soff G, Balduzzi A, Cooper N, Lawrence T, Semple JW. A Review of romiplostim mechanism of action and clinical applicability. Drug Des Devel Ther. 2021;15:2243\u201368.","journal-title":"Drug Des Devel Ther"},{"key":"3453_CR4","first-page":"797","volume":"90","author":"Consortium TIF","year":"1997","unstructured":"Consortium TIF. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Int FMF Consort Cell. 1997;90:797\u2013807.","journal-title":"Int FMF Consort Cell"},{"key":"3453_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2017.00043","volume":"8","author":"C de Torre-Minguela","year":"2017","unstructured":"de Torre-Minguela C, Mesa Del Castillo P, Pelegr\u00edn P. The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases. Front Immunol. 2017;8:43.","journal-title":"Front Immunol"},{"key":"3453_CR6","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s10067-017-3715-5","volume":"36","author":"M Alghamdi","year":"2017","unstructured":"Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017;36:1707\u201313.","journal-title":"Clin Rheumatol"},{"key":"3453_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","volume":"371","author":"DJ Kuter","year":"2008","unstructured":"Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371:395\u2013403.","journal-title":"Lancet"},{"issue":"Suppl 127","key":"3453_CR8","first-page":"76","volume":"38","author":"D Kishida","year":"2020","unstructured":"Kishida D, Nakamura A, Yazaki M, Oka K, Tsuchiya-Suzuki A, Ichikawa T, et al. Triggering factors for febrile attacks in Japanese patients with familial Mediterranean fever. Clin Exp Rheumatol. 2020;38(Suppl 127):76\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"3453_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00296-012-2453-x","volume":"33","author":"O Karadag","year":"2013","unstructured":"Karadag O, Tufan A, Yazisiz V, Ureten K, Yilmaz S, Cinar M, et al. The factors considered as trigger for the attacks in patients with familial Mediterranean fever. Rheumatol Int. 2013;33:893\u20137.","journal-title":"Rheumatol Int"},{"key":"3453_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12185-009-0336-z","volume":"90","author":"K Sasaki","year":"2009","unstructured":"Sasaki K, Tahara T, Mitani K. Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome. Int J Hematol. 2009;90:91\u20133.","journal-title":"Int J Hematol"},{"key":"3453_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/030089160308900116","volume":"89","author":"E Toubi","year":"2003","unstructured":"Toubi E, Gershoni-Baruch R, Kuten A. Cisplatin treatment triggers familial Mediterranean fever attacks. Tumori. 2003;89:80\u20131.","journal-title":"Tumori"},{"key":"3453_CR12","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s11033-020-06040-y","volume":"48","author":"A Arpac\u0131","year":"2021","unstructured":"Arpac\u0131 A, Do\u011fan S, Erdo\u011fan HF, El \u00c7, Cura SE. Presentation of a new mutation in FMF and evaluating the frequency of distribution of the MEFV gene mutation in our region with clinical findings. Mol Biol Rep. 2021;48:2025\u201333.","journal-title":"Mol Biol Rep"},{"key":"3453_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gene.2012.06.074","volume":"506","author":"S Yigit","year":"2012","unstructured":"Yigit S, Karakus N, Tasliyurt T, Kaya SU, Bozkurt N, Kisacik B. Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients. Gene. 2012;506:43\u20135.","journal-title":"Gene"},{"key":"3453_CR14","first-page":"104","volume":"19","author":"S Kutlay","year":"2006","unstructured":"Kutlay S, Sengul S, Keven K, Erturk S, Erbay B. Two sisters with familial Mediterranean fever: lack of correlation between genotype and phenotype? J Nephrol. 2006;19:104\u20137.","journal-title":"J Nephrol"},{"key":"3453_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/MD.0000000000000029","volume":"93","author":"K Migita","year":"2014","unstructured":"Migita K, Agematsu K, Yazaki M, Nonaka F, Nakamura A, Toma T, et al. Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore). 2014;93:158\u201364.","journal-title":"Medicine (Baltimore)"},{"key":"3453_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/sj.ejhg.5200658","volume":"9","author":"I Touitou","year":"2001","unstructured":"Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet. 2001;9:473\u201383.","journal-title":"Eur J Hum Genet"},{"key":"3453_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-015-0252-7","volume":"10","author":"I Ben-Zvi","year":"2015","unstructured":"Ben-Zvi I, Herskovizh C, Kukuy O, Kassel Y, Grossman C, Livneh A. Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis. 2015;10:34.","journal-title":"Orphanet J Rare Dis"},{"key":"3453_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ejmg.2015.11.007","volume":"58","author":"JN Ibrahim","year":"2015","unstructured":"Ibrahim JN, Chouery E, Lecron JC, M\u00e9garban\u00e9 A, Medlej-Hashim M. Study of the association of IL-1\u03b2 and IL-1RA gene polymorphisms with occurrence and severity of Familial Mediterranean fever. Eur J Med Genet. 2015;58:668\u201373.","journal-title":"Eur J Med Genet"},{"key":"3453_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1080\/14397595.2017.1285845","volume":"27","author":"T Wada","year":"2017","unstructured":"Wada T, Toma T, Matsuda Y, Yachie A, Itami S, Taguchi YH, et al. Microarray analysis of circulating microRNAs in familial Mediterranean fever. Mod Rheumatol. 2017;27:1040\u20136.","journal-title":"Mod Rheumatol"},{"key":"3453_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00296-020-04541-4","volume":"41","author":"EM Karpuzoglu","year":"2021","unstructured":"Karpuzoglu EM, KislaEkinci RM, Balci S, Bisgin A, Yilmaz M. Altered expression of apoptosis-related, circulating cell-free miRNAs in children with familial Mediterranean fever: a cross-sectional study. Rheumatol Int. 2021;41:103\u201311.","journal-title":"Rheumatol Int"},{"key":"3453_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2350-12-105","volume":"12","author":"AK Kirectepe","year":"2011","unstructured":"Kirectepe AK, Kasapcopur O, Arisoy N, CelikyapiErdem G, Hatemi G, Ozdogan H, et al. Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever. BMC Med Genet. 2011;12:105.","journal-title":"BMC Med Genet"},{"key":"3453_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/annrheumdis-2012-202708","volume":"73","author":"S Ozen","year":"2014","unstructured":"Ozen S, Demirkaya E, Amaryan G, Kon\u00e9-Paut I, Polat A, Woo P, et al. Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis. 2014;73:662\u20137.","journal-title":"Ann Rheum Dis"},{"key":"3453_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/ard.2008.092031","volume":"68","author":"S Ozen","year":"2009","unstructured":"Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis. 2009;68:246\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3453_CR24","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.1542\/peds.105.5.e70","volume":"105","author":"A Mimouni","year":"2000","unstructured":"Mimouni A, Magal N, Stoffman N, Shohat T, Minasian A, Krasnov M, et al. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics. 2000;105:E70.","journal-title":"Pediatrics"},{"key":"3453_CR25","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/art.22507","volume":"56","author":"I Touitou","year":"2007","unstructured":"Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007;56:1706\u201312.","journal-title":"Arthritis Rheum"},{"key":"3453_CR26","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1182\/blood-2006-10-019315","volume":"109","author":"DJ Kuter","year":"2007","unstructured":"Kuter DJ. New thrombopoietic growth factors. Blood. 2007;109:4607\u201316.","journal-title":"Blood"},{"key":"3453_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107615","volume":"31","author":"V Rolfes","year":"2020","unstructured":"Rolfes V, Ribeiro LS, Hawwari I, B\u00f6ttcher L, Rosero N, Maasewerd S, et al. Platelets fuel the inflammasome activation of innate immune cells. Cell Rep. 2020;31: 107615.","journal-title":"Cell Rep"},{"key":"3453_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12185-012-1061-6","volume":"95","author":"C Oktenli","year":"2012","unstructured":"Oktenli C, Celik S. High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility? Int J Hematol. 2012;95:380\u20135.","journal-title":"Int J Hematol"},{"key":"3453_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2018-03-784116","volume":"132","author":"L Barreyro","year":"2018","unstructured":"Barreyro L, Chlon TM, Starczynowski DT. Chronic immune response dysregulation in MDS pathogenesis. Blood. 2018;132:1553\u201360.","journal-title":"Blood"},{"key":"3453_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fonc.2016.00151","volume":"6","author":"DA Sallman","year":"2016","unstructured":"Sallman DA, Cluzeau T, Basiorka AA, List A. Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype. Front Oncol. 2016;6:151.","journal-title":"Front Oncol"},{"key":"3453_CR31","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","volume":"128","author":"AA Basiorka","year":"2016","unstructured":"Basiorka AA, McGraw KL, Eksioglu EA, Chen X, Johnson J, Zhang L, et al. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype. Blood. 2016;128:2960\u201375.","journal-title":"Blood"},{"key":"3453_CR32","unstructured":"Ministry of health, labour and welfare. Review reports. Romiplostim. 2010;34."},{"key":"3453_CR33","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","volume":"104","author":"W Ghanima","year":"2019","unstructured":"Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104:1112\u201323.","journal-title":"Haematologica"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03453-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03453-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03453-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:59:12Z","timestamp":1675184352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03453-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3453"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03453-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"8 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All except two of the authors report that they have no conflict of interest to disclose. Shigeru Kusumoto has received honoraria and research funding from Chugai Pharmaceutical Co., Ltd. and Kyowa Kirin Co., Ltd. Tomotaka Suzuki has received honoraria from Chugai Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}